Effect of α-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity

Brain Research

Volumn 1109, Issue 1, 2006, Pages 176-182

  Park, Mee Jung ^a   Lee, Sang Ki ^a   Lim, Mi Ae ^a   Chung, Hee Sun ^a   Cho, Sung Ig ^b   Jang, Choon Gon ^c   Lee, Sun Mee ^c  

^a National Institute of Scientific Investigation   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Dopamine; Free radical; Methamphetamine; Neuronal damage

Indexed keywords

ALPHA TOCOPHEROL; DEFEROXAMINE; DOPAMINE; GLUTATHIONE; IRON CHELATING AGENT; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTHERMIA; LIPID PEROXIDATION; LOCOMOTION; MALE; NERVE CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; BIOGENIC MONOAMINES; BODY TEMPERATURE; CORPUS STRIATUM; DEFEROXAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; GLUTATHIONE; LIPID PEROXIDATION; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33747769640     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.06.030     Document Type: Article

References (32)

1. Ali S.F., Newport R.P., Holson W., Slikker Jr. W., and Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658 (1994) 33-38
2. Anderson M. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113 (1985) 548-555
3. Benzi G., and Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biol. Med. 19 (1995) 77-101
4. Bryan C.L., Patefield A.J., Cohen D., Nielsen J.L., Emanuel B., and Calhoon J.H. Assessment of injury in transplanted and nontransplanted lungs after 6 h of cold storage with glutathione. J. Appl. Physiol. 76 (1994) 1232-1241
5. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
6. Burton G.W., and Ingold K.U. Vitamin E as an in vitro and in vivo antioxidant. Ann. N. Y. Acad. Sci. 570 (1989) 7-22
7. Burton G.W., Ingold K.U., Foster D.O., Cheng S.C., Webb A., Hughes L., and Lusztyk E. Comparison of free α-tocopherol and α-tocopherol acetate as sources of vitamin E in rats and humans. Lipids 23 (1988) 834-840
8. Cadet J.L., and Brannock C. Free radicals and pathobiology of brain dopamine system. Neurochem. Int. 32 (1997) 117-131
9. Cappon G.D., Broening H.W., Pu C., Morford L., and Vorhees C.V. α-Phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24 (1996) 173-181
10. Cass W.A. Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. J. Neurochem. 74 (2000) 1079-1085
11. DeVito M.J., and Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28 (1989) 1145-1150
12. Goss-Sampson M.A., MacEvilly C.J., and Muller D.P. Longitudinal studies of the neurobiology of vitamin E and other antioxidant systems, and neurological function in the vitamin E deficient rat. J. Neurol. Sci. 87 (1988) 25-35
13. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinines. Mol. Pharmacol. 14 (1978) 633-643
14. Griffith O.W., and Mulcahy R.T. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv. Enzymol. Relat. Areas Mol. Biol. 73 (1999) 209-267
15. Halliwell B., and Gutteridge J.M. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett. 307 (1992) 108-112
16. Hurn P.D., Koehler R.C., Blizzard K.K., and Traystman R.J. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 26 (1995) 688-694
17. Ikeda Y., Ikeda K., and Long D.M. Comparative study of different iron-chelating agents in cold-induced brain edema. Neurosurgery 24 (1989) 820-824
18. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., and Pallas M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 196 (2004) 223-234
19. Lucot J.B., Wagner G.C., Schuster C.R., and Seiden L.S. The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine. Pharmacol. Biochem. Behav. 13 (1980) 409-413
20. Modell B., Letsky E.A., Flynn D.M., Peto R., and Weatherall D.J. Survival and desferrioxamine in thalassanemia major. Br. Med. J. (Clin. Res. Ed.) 284 (1982) 1081-1084
21. Niu K.C., Lin K.C., Yang C.Y., and Lin M.T. Protective effects of alpha-tocopherol and mannitol in both circulatory shock and cerebral ischaemia injury in rat heatstroke. Clin. Exp. Pharmacol. Physiol. 30 (2003) 745-751
22. O'Callaghan J.P., and Miller D.B. Neurotoxicity amphetamine analogues: effects in monkeys and implications for humans. Ann. N. Y. Acad. Sci. 648 (1994) 371-382
23. Packer L. Interactions among antioxidants in health and disease: vitamin E and its redox cycle. Proc. Soc. Exp. Biol. Med. 200 (1992) 271-276
24. Peeters-Scholte C., Braun K., Koster J., Kops N., Blomgren K., Buonocore G., van Buul-Offers S., Hagberg H., Nicolay K., van Bel F., and Groenendaal F. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr. Res. 54 (2003) 516-522
25. Richarte G.A., Seiden L.A., and Schuster C.R. Increased dopamine metabolism in rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology 22 (1983) 1383-1388
26. Segal D.S., and Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci. 17 (1997) 2551-2566
27. Seyfried J., Soldner F., Kunz W.S., Schulz J.B., Klockgether T., Kovar K.A., and Wullner U. Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells. Neurochem. Int. 36 (2000) 489-497
28. Sofic E., Paulus W., Jellinger K., Riederer P., and Youdim M.B.H. Selective increase of iron in the substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 56 (1991) 978-982
29. Traber M.G., and Packer L. Vitamin E: beyond antioxidant function. Am. J. Clin. Nutr. 62 (1995) 1501s-1509s
30. Van der Worp H.B., Bar P.R., Kappelle L.J., and de Wildt D.J. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats. Stroke 29 (1998) 1002-1005
31. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., and Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2 (1996) 699-703
32. Yamamoto B.K., and Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287 (1998) 107-114